FDA Watch: OraSure’s Collection Device for Cobas STI Testing Receives Approval
At-home sample collections can be mailed to a clinical laboratory
At-home sample collections can be mailed to a clinical laboratory
From – National Intelligence Report
With another hurricane season wreaking havoc, the FDA’s Center for Biologics Evaluation and Research (CBER), which regulates…
From – National Intelligence Report
On June 15, the FDA issued a new guidance document clarifying the rules for laboratory coding of in vitro diagnostic tests. There are four…
From – National Intelligence Report
Test makers have long complained about the FDA’s unwillingness to embrace technology and diagnostics advances. But on April 13, the agency took steps to address…
From – National Intelligence Report
One of the reasons Abbott Laboratories got cold feet about consummating the $5.3 billion Alere acquisition was concern over the legal proceedings against the…
From – National Intelligence Report
On March 6, the FDA announced its first ever approval of a direct-to-consumer breast cancer gene test…